Platelet Factor 4 Variant 1 (PF4V1) (Middle Region) Peptide
-
- Target See all PF4V1 products
- PF4V1 (Platelet Factor 4 Variant 1 (PF4V1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PF4V1 antibody (Catalog #: ARP42053_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PF4V1 (Platelet Factor 4 Variant 1 (PF4V1))
- Synonyms
- PF4A Peptide, CXCL4L1 Peptide, CXCL4V1 Peptide, PF4-ALT Peptide, SCYB4V1 Peptide, PF4V1 Peptide, platelet factor 4 variant 1 Peptide, PF4V1 Peptide
- Background
-
PF4V1 is the inhibitor of angiogenesis. PF4V1 is the inhibitor of endothelial cell chemotaxis (in vitro).
Alias Symbols: CXCL4V1, PF4-ALT, PF4A, SCYB4V1, CXCL4L1
Protein Size: 104 - Molecular Weight
- 11 kDa
- Gene ID
- 5197
- NCBI Accession
- NM_002620, NP_002611
- UniProt
- P10720
-